Prescription trends for obesity medications surge, tied to growing interest in GLP-1 drugs
Month-to-month prescriptions for weight problems medicines reached 1.5 million in February 2024, with semaglutide (Wegovy) and tirzepatide (Zepbound) gaining market ...